Highlights:
- Contract Extension Secured: Hydrix Services, a wholly owned subsidiary, has entered into a AU$2.8 million contract extension with Paul Hartmann AG as part of a multi-stage product development program.
- Revenue Recognition: Hydrix expects the contract extension to be completed by September 2025, contributing to its cumulative revenue from previous contract stages, which totals AU$3.7 million.
- Market Reaction: The news prompted a remarkable 220% increase in Hydrix’s share price, now trading at 3.1 cents as of 23 January 2025.
Hydrix Limited (ASX:HYD) has seen its share price surge by a staggering 220%, reaching 3.1 cents per share following the announcement of a AU$2.8 million contract extension with Paul Hartmann AG, a leading European medical device company.
Strategic Partnership with Paul Hartmann AG
This contract extension marks a significant milestone for Hydrix, as it continues to expand its business and deepen its relationship with Paul Hartmann AG. The extension covers a new phase of work in Hartmann’s ongoing product development program, reinforcing Hydrix’s position as a trusted partner in the medical device industry.
The anticipated AU$2.8 million in revenue from this stage of the contract is expected to be fully recognized by the end of September 2025, bringing the total revenue from the Hartmann partnership to AU$6.5 million.
Investor Confidence and Market Impact
The news has been met with strong enthusiasm in the market, with Hydrix’s share price soaring by 220% to 3.1 cents per share. This sharp rise reflects investor optimism over the company’s expanding order book, strategic partnerships, and potential for continued growth.